About Factor VIII Inhibitor By passing activity (in 20-60 mg human plasma protein)
            
            Class: | Hemostatic agent, Factor VIII inhibitor bypassing activity  
Use: | Treatment of bleeding episodes in patients with hemophilia A or B who have developed inhibitors to Factor VIII  
Adult dose: | 50 U/kg administered intravenously; may repeat every 6-12 hours based on clinical response  
Pediatric dose: | 50 U/kg administered intravenously; may repeat every 6-12 hours based on clinical response  
Side effects: | Thromboembolic events, headache, fever, nausea, vomiting, allergic reactions
         
        
            
                
                
                    
                        Drug Class
                    
                    Hemostatic agent, Factor VIII inhibitor bypassing activity
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of bleeding episodes in patients with hemophilia A or B who have developed inhibitors to Factor VIII
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; reconstituted solution should be used immediately or stored at 2°C to 8°C for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Takeda Manufacturing Austria AG (Vienna Austria), Austria
                    
                    
                    Package Size
                    20 ml kit (1 glass vial of 1000 u FEIBA (powder)+1 Glass vial of 20ml sterilised WFI + 1  BAXJECT II  HI-Flow + 1 disposable syringe  20 ml + 1 butterfly needle + 1 disposable needle)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4180.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        50 U/kg administered intravenously; may repeat every 6-12 hours based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        50 U/kg administered intravenously; may repeat every 6-12 hours based on clinical response
                    
                 
                
                
                    
                        Side Effects
                    
                    Thromboembolic events, headache, fever, nausea, vomiting, allergic reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to any component of the product; history of thromboembolic events
         
        
        
            
                Important Warnings
            
            Risk of thrombosis; monitor for signs of thromboembolic events; use with caution in patients with risk factors for thromboembolism
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.